| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.9 |
| Metabolic Syndrome |
0 |
0.79 |
| Liver Disease |
0 |
0.71 |
| Liver |
0 |
0.7 |
| Alcohol Use |
0 |
0.59 |
| Fatty Liver |
0 |
0.58 |
| Hepatic Fibrosis |
0 |
0.57 |
| Hepatocellular Carcinoma |
0 |
0.45 |
| Heart |
0 |
0.1 |
| Metabolism |
0 |
0.1 |
| Blood |
0 |
0.05 |
| Cirrhosis |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Obesity |
0 |
0.05 |
| Neuroendocrine Tumor |
0 |
0.04 |
| Body Mass Index |
0 |
0.03 |
| Cancer |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Exercise |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Investment |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Kidney |
0 |
0.03 |
| Lung |
0 |
0.03 |
| Nonalcoholic Steatohepatitis |
0 |
0.03 |
| Residency |
0 |
0.03 |
| Translational Research |
0 |
0.03 |
| Transplantation |
0 |
0.03 |